Effects of Shoe Cushioning and Body Mass on Injury Risk in Running (RRI_Interv4)

Role of Shoe Cushioning, Body Mass and Running Biomechanics on Injury Risk: a Randomized Controlled Trial

The main goal is to investigate the influence of shoe cushioning and body mass on the risk of running-related injury. This study will allow to determine if shoe cushioning needs to be adapted to the mass of the runner in order to minimize injury risk. The influence of shoe cushioning on running technique will also be investigated.

This study consists in a 6-month follow-up period during which leisure-time runners are required to perform a running activity at least once a week and to upload all their running as well as other sporting activities onto a secured web-based training calendar named "Training and Injury Prevention Platform for Sports" (TIPPS) on a weekly basis. Any injury sustained during this period should also be uploaded onto the TIPPS system using the injury questionnaire provided on the website. Finally, the day of the visit to the laboratory (study start), their running style will be analysed during a 15-minute run on an instrumented treadmill at the participant's usual running speed. Anthropometric measurements will also taken.

Before the beginning of the study, the participants will receive a pair of running shoes free of charge. These shoes will either have a soft or hard sole. Both shoe versions have cushioning properties that correspond to the range of values from the shoes available on the market. They will be administered through random allocation. Neither the participants nor the research team will know which shoe version was provided to the participant, in order to respect the double-blinded methodology of this study. The participants will be required to use these shoes for all running sessions, and only for running activities.

Hypotheses:

H1: Running shoes with greater stiffness are associated with a higher injury risk in leisure-time runners.

H2: High body mass is associated with a higher injury risk in leisure-time runners.

H3: Runners with a high body mass experience a lower injury risk in shoes with greater stiffness.

H4: A higher step length, a lower step frequency, and higher peak vertical impact forces are associated with a higher injury risk.

H5: Running shoes with greater stiffness will be associated with higher vertical impact peak forces and a shorter contact time.

H6: High body mass will be associated with higher peak vertical impact forces, increased contact time, increased duty factor, and decreased step frequency.

Study Overview

• Status: Completed
• Conditions: Running-Related Injury (First-time)
• Intervention / Treatment: Other: Hard cushioned running shoes; Other: Soft cushioned running shoes

Detailed Description

The design of this study is a randomized controlled trial with an intervention period of six months and a biomechanical analysis of running pattern the day of inclusion in the study. Running footwear is provided by a renowned sport equipment manufacturer working in close collaboration with the Sports Medicine Research Laboratory (SMRL) of the Luxembourg Institute of Health (LIH), which in turn is responsible for the management and execution of the study. Random allocation of the study shoes, recruitment and follow-up of the participants, biomechanical testing, as well as data management and analysis will be carried out by the SMRL. The study design is based on the comparison between 2 running shoe prototypes, which only differ with respect to the cushioning (i.e. stiffness). The cushioning properties of both shoe versions will be within the range of values of models available on the market.

Recruitment:

Participants will be recruited through advertisements in local newspapers and press releases within the Grand-Duchy of Luxembourg during the months of September 2017 to January 2018. The benefits for the participants are strongly highlighted during the recruitment phase, and are as follows: 1) the use of a sports diary developed by the SMRL and called TIPPS (Training and Injury Prevention Platform for Sports, www.tipps.lu) to record all their sporting activities, quantify progress, and keep track of their sport-related injuries, 2) a free pair of running shoes, and 3) a brief report with the results of the biomechanical testing as well as their anthropometric measurements. However participants will be made aware that they will randomly receive one of the 2 study shoe versions to be worn during the observation period for all their running activities.

Registration procedure:

The participants must understand and agree on the randomized design of the study and that they will be allocated to one of the two running shoe groups. Anyone wishing to take part and believing themselves to meet the inclusion criteria will be invited to follow the process described hereafter:

Volunteers first have to create a personal account on TIPPS, pre-register to the study via their personal account, and answer an online inclusion/exclusion questionnaire as well as a baseline questionnaire. To finalize the registration, the participant will have to set an appointment with the research team via the TIPPS platform. Answers to both questionnaires will be assessed by the investigators during the initial visit.

Data collection:

The data collection phase of this project will last from September 2017 until July 2018. It consists of 2 different parts: an epidemiological study with 6-month follow-up and a biomechanical analysis of the participants' running pattern.

The follow-up period will start as soon as the participants have received their study shoes (from September 2017 to January 2018) and will finish at the latest on the 31st of July 2018.

The biomechanical analysis of the participants' running pattern will occur during their initial visit, using the study shoes that they will have received.

The initial visit of the participants at the SMRL will be the occasion 1) to verify the inclusion criteria, 2) to validate their answers to the online questionnaire, 3) to determine the appropriate shoe size, 4) to allocate each participant to one of the study arms according to the randomization list (see stratified randomization), 4) to deliver the shoes, 5) to collect some anthropometric measures, and 6) to perform the biomechanical test on the treadmill.

Stratified randomization:

A stratified block randomization will be prepared by the Competence Center for Methodology and Statistics of the LIH before the beginning of the recruitment. Participants will be stratified according to their sex because body mass (one of the two variables of interest) as well as many anthropometric characteristics are largely dependent on sex. Each block will include 40 participants.

Shoe types:

The study shoes are prototypes and will be anonymized for the purpose of this trial. The sole of the shoes will be customized so that the two running shoe prototypes will be exactly the same (same midsole, same outsole, same upper), except for their cushioning properties which will differ by more than 35%, while remaining within the range of the shoes available on the market. The difference in cushioning properties between the shoe versions will be created by modifying the midsole material, i.e. chemistry, density and therefore the hardness of the Ethylene Vinyl Acetate (EVA) foam. In order to provide accurate data on the technical specifications (i.e. stiffness ) of each shoe model, a set of 40 shoes (10 pairs per condition) will be tested for cushioning properties by the manufacturer according to a standardized protocol (Impact test: ASTM1614, Procedure A).

Data on exposure:

Data on running practices is collected using the TIPPS system. Required information in the sport activity report includes the type of activity, context, duration, subjectively perceived intensity, distance, shoe pair used, running surface (hard or soft), and whether the participant had experienced any pain during the session forcing him/her to reduce practice volume or intensity, or to interrupt the practice. Session intensity is determined using the Borg's rating of perceived exertion scale, a subjective 10-point scale.

Data on outcome:

The primary outcome is the first running-related injury. A consensus definition of running-related injury in recreational runners has been recently published. The definition of running-related injury is a "running-related (training or competition) musculoskeletal pain in the lower limbs that causes a restriction on or stoppage of running (distance, speed, duration, or training) for at least 7 days or 3 consecutive scheduled training sessions, or that requires the runner to consult a physician or other health professional." Similar to uploading a training session or competition, the TIPPS provides a complete yet easy to fill in questionnaire when reporting an injury. Information regarding the following is required: injury date, context, sports discipline, injury mechanism (acute or progressive), anatomical location, type of injury, description and estimated return date. Running-related injury will be classified according to the Orchard Sports Injury Classification System version 10 (OSICS-10). Injury severity will be measured in days of modified or interrupted training.

Anthropometric measures:

The body composition (i.e. the proportion of muscle and fat tissues) will be assessed by bioelectrical impedance analysis (Tanita SC-240 MA).

Leg length will be defined as the measure between the anterior superior iliac spine and the medial malleolus, and is referred to as the "direct" clinical method. Additionally, the distance between the great trochanter and the ground will also be measured for the assessment of leg stiffness.

Biomechanical testing:

The biomechanical testing consists in a running test on an instrumented treadmill and will be performed in the study shoes, according to the random allocation. The test (10 minutes) consists of a 5-minute warm-up followed by a 5-minute run at the self-declared preferred (habitual) running speed. Two records of 45 seconds will be obtained over the last 2 minutes of the test.

Additionally, the participants who reported a preferred running speed equal to 10 km/h (+/- 1 km/h) will be invited to perform a second test at the end of the follow-up period. This second test will consist in 10 minutes of running in each shoe model. Records will be obtained during the last 2 minutes of each run. This will allow a within subject analysis of the shoe effect on running biomechanics at a standardized speed.

Sample size:

A sample size calculation for Cox regression was used to determine the number of participants needed for the primary hypothesis of the study. With an alpha of 0.05 and a power of 80%, an average injury rate of 30%, an expected HR=1.50 between groups, 50% of participants randomized to each shoe group and an expected drop-out rate of 20%, the total number of participants required is 802.

A within subject analysis will be performed on a subgroup of participants to investigate the effect of shoe condition on VGRF. A total sample of 39 participants will be required to detect a difference of 0.16 body weight (standard deviation: 0.25 body weight) between shoe conditions with 80% power and a significant level of 5%.

Statistical analysis:

Descriptive data for the personal, anthropometric, biomechanical and training-related characteristics will be presented as count and percentage for dichotomous variables, and as mean and standard deviation, or as median and range, respectively, for normally and non-normally distributed continuous variables. Average sport-related characteristics will be computed for each participant over their specific period of observation. Shock absorption properties of the two types of shoes will be compared using a Student's t test. A two-way analysis of variance (ANOVA) will be used to determine whether any difference in running biomechanics results from the shoe cushioning properties or body mass.

Cox proportional hazards regressions will be used to compute the hazard rates (HR) in the exposure groups, using first-time injury as the primary outcome. Date of inclusion (baseline evaluation date) and date of injury or of censoring will be basic data used to calculate the time at risk, which is expressed in hours spent running and defined as the time-scale. A participant will be right-censored if injury unrelated to running or severe disease caused a modification of the running plan, or at the end of follow-up. The assumption of proportional hazards will be evaluated by log-minus-log plots.

Unadjusted Cox regressions will be performed to present the crude estimates of HRs for shoe model, body mass and other potential risk factors such as running biomechanics variables and training-related characteristics. Body mass is an exposure that can change over time (time-dependent covariate). This means that each participant could move between exposure states continuously (every month in our study). A delayed entry will be used in the unadjusted Cox regression model for body mass.

Subsequently, the variables with a P value <0.200 will be included in the adjusted Cox regression analysis to determine whether shoe cushioning and/or body mass are associated with injury risk, controlling for potential confounders. The recommendation for using at least 10 injuries per predictor variable included in the Cox regression analysis will be strictly followed.

Finally, to investigate if the effect of shoe cushioning on injury risk is modified by body mass, a stratified analysis will be performed. HRs and their 95% confidence intervals (CI) will be determined within each stratum. All analyses will be performed using STATA/SE version 14.

• Study Type: Interventional
• Enrollment (Actual): 874
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Luxembourg
  • Luxembourg, Luxembourg, L-1460
    • Luxembourg Institute of Health

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Aged between 18 and 65 years
• Agree to perform running training minimum once a week
• Agree to use of the pair of running shoes delivered by the research team for each running training session, and only for running activities
• Agree to report all sporting activities, injuries and pains in the electronic system "TIPPS"
• Signed Informed consent
• Capable of performing 15 min of consecutive running

Exclusion Criteria:

• Any contraindication to running training and testing including cardiovascular/respiratory disease or running impeding injury/condition at the time of initial inclusion
• A history of surgery to the lower limbs or the back region within the previous 12 months or any degenerative conditions
• The use of insoles for physical activity
• Any current running-related injury

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Quadruple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Hard cushioned running shoes; Running shoes with cushioned properties among the hardest of the market benchmark (Stiffness: +/- 90 N/mm)	Other: Hard cushioned running shoes; The participants allocated to this experimental group will have to perform all their running sessions with the study shoes they received the day of their inclusion to the study and characterized by hard cushioning.; Other Names: Hard
Experimental: Soft cushioned running shoes; Running shoes with cushioned properties among the softest of the market benchmark (Stiffness: +/- 57 N/mm)	Other: Soft cushioned running shoes; The participants allocated to this experimental group will have to perform all their running sessions with the study shoes they received the day of their inclusion to the study and characterized by soft cushioning.; Other Names: Soft

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Running-related injury (First-time)	First running-related (training or competition) musculoskeletal pain in the lower limbs that causes a restriction on or stoppage of running for at least 7 days or 3 consecutive scheduled training sessions.	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Running-related injury (subsequent)	Any subsequent running-related (training or competition) musculoskeletal pain in the lower limbs that causes a restriction on or stoppage of running for at least 7 days or 3 consecutive scheduled training sessions.	6 months
Step frequency (steps/min)	Steps per minute measured during the running technique analysis at baseline	Baseline
Contact time (ms)	Duration of the contact phase measured during the running technique analysis at baseline	Baseline
Flight time (ms)	Duration of the flight phase measured during the running technique analysis at baseline	Baseline
Duty factor (%)	Ratio between contact time and stride time	Baseline
Step length (m)	Distance between 2 consecutive steps of the same foot calculated based on running speed and stride time	Baseline
Vertical Impact Peak Force (N)	Amplitude of the first impact peak during the stance phase	Baseline
Peak Vertical Force (N)	Maximal value of the vertical force during the stance phase	Baseline
Vertical Instantaneous Loading Rate (N/s)	The steepest slope of the curve of vertical ground reaction force from initial contact to vertical impact peak force	Baseline
Vertical Average Loading Rate (N/s)	Average increase of vertical force from initial contact to vertical impact peak force	Baseline
Peak Power (W)	Highest value measure for power during the eccentric phase of the stance phase	Baseline
Time to Peak Power (ms)	Time from intial contact to peak power	Baseline
Leg stiffness (kN/m)	Maximal vertical ground reaction force divided by the peak displacement of the leg spring calculated from the initial leg length, running velocity and contact time.	Baseline
Vertical stiffness (kN/m)	Maximal vertical ground reaction force divided by the vertical displacement of the center of mass	Baseline

Collaborators and Investigators

• Sponsor: Luxembourg Institute of Health
• Collaborators: DECATHLON SA
• Investigators: Study Director: Daniel Theisen, PhD, Luxembourg Institute of Health

Publications and helpful links

General Publications

• Malisoux L, Gette P, Delattre N, Urhausen A, Theisen D. Spatiotemporal and Ground-Reaction Force Characteristics as Risk Factors for Running-Related Injury: A Secondary Analysis of a Randomized Trial Including 800+ Recreational Runners. Am J Sports Med. 2022 Feb;50(2):537-544. doi: 10.1177/03635465211063909. Epub 2022 Jan 20.
• Malisoux L, Gette P, Backes A, Delattre N, Theisen D. Lower impact forces but greater burden for the musculoskeletal system in running shoes with greater cushioning stiffness. Eur J Sport Sci. 2022 Jan 19:1-11. doi: 10.1080/17461391.2021.2023655. Online ahead of print.
• Malisoux L, Gette P, Backes A, Delattre N, Cabri J, Theisen D. Relevance of Frequency-Domain Analyses to Relate Shoe Cushioning, Ground Impact Forces and Running Injury Risk: A Secondary Analysis of a Randomized Trial With 800+ Recreational Runners. Front Sports Act Living. 2021 Nov 11;3:744658. doi: 10.3389/fspor.2021.744658. eCollection 2021.
• Malisoux L, Delattre N, Meyer C, Gette P, Urhausen A, Theisen D. Effect of shoe cushioning on landing impact forces and spatiotemporal parameters during running: results from a randomized trial including 800+ recreational runners. Eur J Sport Sci. 2021 Jul;21(7):985-993. doi: 10.1080/17461391.2020.1809713. Epub 2020 Sep 12.
• Malisoux L, Delattre N, Urhausen A, Theisen D. Shoe Cushioning Influences the Running Injury Risk According to Body Mass: A Randomized Controlled Trial Involving 848 Recreational Runners. Am J Sports Med. 2020 Feb;48(2):473-480. doi: 10.1177/0363546519892578. Epub 2019 Dec 26.
• Malisoux L, Delattre N, Urhausen A, Theisen D. Shoe cushioning, body mass and running biomechanics as risk factors for running injury: a study protocol for a randomised controlled trial. BMJ Open. 2017 Aug 21;7(8):e017379. doi: 10.1136/bmjopen-2017-017379.

Helpful Links

• Portal of the electronic system used for the recruitment of the participants and the data collection
• Official website of the Luxembourg Institute of Health

Study record dates

Study Major Dates

• Study Start (Actual): September 20, 2017
• Primary Completion (Actual): July 31, 2018
• Study Completion (Actual): October 31, 2018

Study Registration Dates

• First Submitted: March 30, 2017
• First Submitted That Met QC Criteria: April 11, 2017
• First Posted (Actual): April 14, 2017

Study Record Updates

• Last Update Posted (Actual): February 26, 2019
• Last Update Submitted That Met QC Criteria: February 25, 2019
• Last Verified: February 1, 2019

More Information

Terms related to this study

• Keywords: Epidemiology; Body mass; Running-related injury; Sports injury prevention; Impact forces; Running biomechanics; Sports footwear; Shoe cushioning
• Additional Relevant MeSH Terms: Wounds and Injuries
• Other Study ID Numbers: DOPH_SMRL_20161101

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No
• IPD Plan Description: The IPD will not be shared.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No